Genetic screening of familial Mediterranean fever mutations in the Palestinian population

Suhail K Ayesh1, Suheir M Nassar, Wasif A Al-Sharef

  • 1Molecular Genetics Laboratory, Makassed Islamic Charitable Hospital, Mount of Olives, PO Box 19482, Jerusalem 91194, Palestine. moleclab@alqudsnet.com

Saudi Medical Journal
|June 14, 2005
PubMed
Abstract

Insights

Familial Mediterranean fever (FMF) genetic analysis in Palestinian patients revealed predominantly homozygous genotypes. Further research is needed to identify unknown mutations in individuals with only one identified pyrin gene mutation.

Area of Science:

  • Genetics
  • Molecular Biology
  • Clinical Medicine

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
  • The pyrin gene (MEFV) is the primary genetic determinant of FMF.
  • Understanding mutation spectrum and genotypes is crucial for FMF diagnosis and management.

Purpose of the Study:

  • To investigate the spectrum of mutations and genotypes in the pyrin gene of FMF patients.
  • To characterize the genetic basis of FMF in the Palestinian population.

Main Methods:

  • Genotyping of 24 different MEFV mutations in 511 suspected FMF patients.
  • Analysis of blood samples collected between June 1999 and August 2004.

Main Results:

  • 14 out of 24 known MEFV mutations were identified.
  • Predominantly homozygous genotypes (38%) were observed.
  • 31.4% of patients had one identified mutation, suggesting potential novel mutations.

Conclusions:

  • FMF in the Palestinian population is largely associated with homozygous genotypes.
  • The high prevalence of single identified mutations warrants future investigation into new MEFV mutations.